Fortress Biotech
FBIO
44 hedge funds and large institutions have $19.7M invested in Fortress Biotech in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
11% more capital invested
Capital invested by funds: $17.7M → $19.7M (+$2.02M)
10% more funds holding
Funds holding: 40 → 44 (+4)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
+$639K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$226K |
| 3 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$132K |
| 4 |
Goldman Sachs
New York
|
+$127K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$122K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
-$1.3M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$119K |
| 3 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$88K |
| 4 |
D.E. Shaw & Co
New York
|
-$59K |
| 5 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
-$37K |
FBIO Hedge Fund Activity: Q1 2016 in Review
44 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2016, worth a combined $19.7M — up 11% from $17.7M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new FBIO positions and 4 closed out — a net gain of 4 holders — while 8 added to existing stakes and 12 trimmed.
The largest buyer was Belmont Global Advisors, adding an estimated $639K. The largest seller was Elliott Management, cutting an estimated $1.3M.
- 44 institutional investors held Fortress Biotech (FBIO) as of Q1 2016, up from 40 in Q4 2015.
- Funds reported $19.7M of Fortress Biotech stock for Q1 2016, up 11% quarter-over-quarter.
- 8 funds opened new Fortress Biotech positions in Q1 2016 and 4 closed out, a net change of +4 holders.
- The largest Fortress Biotech buyer in Q1 2016 was Belmont Global Advisors, an estimated $639K added.
- The largest Fortress Biotech seller in Q1 2016 was Elliott Management, an estimated $1.3M sold.
Based on aggregated 13F filings for Q1 2016.